EN DE
STOCK COMPARISON

CPH Chemie und Papier vs Jiangsu Hengrui Medicine Co: Fair Value & Quality

Both stocks run through our valuation models. Here is how CPH Chemie und Papier (CPHN) and Jiangsu Hengrui Medicine Co (600276) compare, as of Aug 15, 2026.

As of Aug 15, 2026, Fair Value Calculator sees CPH Chemie und Papier as the less overvalued of the two: CPH Chemie und Papier trades at CHF 60.00 versus a fair value of CHF 49.64 (-17%), while Jiangsu Hengrui Medicine Co trades at ¥52.62 versus ¥25.94 (-51%).
CPH Chemie und Papier
CPHN.SW · CHF · Materials
-17%
upside to fair value
overvalued
PriceCHF 60.00
Fair ValueCHF 49.64
Quality67/100
Jiangsu Hengrui Medicine Co
600276.SHG · CNY · Health Care
-51%
upside to fair value
overvalued
Price¥52.62
Fair Value¥25.94
Quality66/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

CPH Chemie und PapierJiangsu Hengrui Medicine Co
Valuation
15.1×P/E (TTM)43.6×
1.26×P/S (TTM)10.84×
2.07×P/B5.76×
8.2×EV/EBITDA33.0×
PEG0.93×
3.5%Dividend yield0.4%
CHF 2.00Dividend per share¥0.20
Profitability
7%Net margin25%
7%Operating margin32%
11%Return on equity15%
6%Return on assets9%
Growth
8%Revenue growth (YoY)13%
-3.4%Avg. growth/yr (3Y)13.9%
-3.1%Avg. growth/yr (5Y)2.5%
Balance & size
0.05×Debt / equity
$421MMarket cap$52B
mixedGrowth qualityhealthy

Jiangsu Hengrui Medicine Co leads: 5 to 7 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

CPH Chemie und Papierof which business quality 64 · market factors 47 Jiangsu Hengrui Medicine Coof which business quality 68 · market factors 42
ProfitabilityMargins and returns on capital today
55
63
Quality GrowthAre margins and returns improving?
60
41
CashflowEarnings quality: real cash, not paper profit
35
82
Fin. StrengthBalance sheet, leverage, solvency risk
79
100
InvestmentDisciplined investing over empire-building
92
27
Low VolatilityCalm price path (market factor)
91
79
MomentumPrice trend over the last 3–12 months (market factor)
32
31
52W MomentumDistance to the 52-week high (market factor)
23
20
Net IssuanceBuybacks instead of dilution
82
64

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

CPH Chemie und Papier

DCF ModelsCHF 42.71
Earnings-BasedCHF 37.57
Dividend DiscountCHF 17.64
MultiplesCHF 70.06
Asset-BasedCHF 22.74
Growth DCFCHF 40.74
Economic ProfitCHF 38.07
Growth EarningsCHF 50.56

17 of 24 models see the stock below the current price.

Jiangsu Hengrui Medicine Co

DCF Models¥37.78
Earnings-Based¥21.29
Dividend Discount¥3.82
Multiples¥23.65
Asset-Based¥6.44
Growth DCF¥39.88
Economic Profit¥18.21
Growth Earnings¥30.99

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

CPH Chemie und Papier
Bear CHF 34.34Fair Value CHF 49.64Bull CHF 66.28
CHF 60.00 = current price (white tick)
Jiangsu Hengrui Medicine Co
Bear ¥19.95Fair Value ¥25.94Bull ¥32.81
¥52.62 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

CPH Chemie und Papier · Materials

Quality score67 · Top 25%
Fair value upside-17% · above median

Jiangsu Hengrui Medicine Co · Health Care

Quality score66 · Top 25%
Fair value upside-51% · below median

Bottom line

As of Aug 15, 2026, Fair Value Calculator sees CPH Chemie und Papier as the less overvalued of the two: CPH Chemie und Papier trades at CHF 60.00 versus a fair value of CHF 49.64 (-17%), while Jiangsu Hengrui Medicine Co trades at ¥52.62 versus ¥25.94 (-51%).

CPH Chemie und Papier has the higher quality score (67/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.